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ABSTRACT High androgen levels have been associated with menstrual irregularities in
clinical populations, but not in healthy women. We examined the association between testoster-
one and menstrual irregularities in a nonclinical population of 194 healthy premenopausal
women, none of whom reported chronic health conditions. Women provided saliva samples for
assay of salivary testosterone, and responded to questions about length of menstrual cycles, vari-
ability in menses, and retrospective history of menstrual irregularity. Results showed significant
correlations between testosterone andmenstrual irregularities, even when women with the most
irregular cycles were excluded from analyses. This pattern was also apparent for a subgroup of
27 women using hormonal contraceptives. Based on our findings, it appears that even in healthy
women reporting no health concerns, menstrual irregularities are associated with higher levels
of circulating androgens. Am. J. Hum. Biol. 18:841–844, 2006. ' 2006Wiley-Liss, Inc.
Menstrual cycles can be important indica-
tors of health and fertility because they reflect
basic physiology, and irregular cycles may be
indicative of underlying endocrine disorders.
For example, elevated androgens have been as-
sociated with dysmenorrhea. Polycystic ovary
syndrome (PCOS) is one well-known disorder
of ovarian dysfunction with dysmenorrhea and
high levels of androgens, as well as obesity and
hirsutism (Rotterdam ESHRE/ASRM-Sponsored
PCOS Consensus Workshop Group, 2004).
Despite the well-established link of high lev-
els of androgens to conditions affecting men-
strual cycles, little research has examined how
androgens and the menstrual cycle may be
associated in healthy women. One study found
that menstrual irregularity was linked with
higher levels of androgens (also stress and
lower insulin sensitivity) in healthy adolescents
with no known clinical diagnosis (Rodrigues
Fernandez et al., 2005; van Hooff et al., 1998);
whether this is true in healthy adult women
remains uninvestigated. Here, we report on
associations between salivary testosterone (T)
andmenstrual irregularity in healthy women.
METHODS
Participants
Participants were recruited as part of other
studies (van Anders andWatson, 2006), approved
by the Simon Fraser University (SFU) Re-
search Ethics Office, from the SFU participant
pool and the Vancouver community. Women
(n ¼ 4) who were pregnant, lactating, or using
noncontraceptive medications were excluded.
Healthy participants were purposively re-
cruited, and none reported health conditions,
including PCOS. There were 194 women
(mean (M) age, 24.48 years; SD, 7.89 years), of
whom 27 were using hormonal contraceptives
(HC; this was exclusionary criteria at most
sites). Some participants did not respond com-
pletely, resulting in a slightly reduced n for
some items. There were 124 heterosexual
women and 68 nonheterosexual women (two
did not respond), determined via the Kinsey
measures (Kinsey et al., 1948). Nonheterosex-
ual women were overrepresented because re-
cruiting partly occurred at the Vancouver
Pride Parade.
Materials and procedure
All samples were collected between 13:00–
20:00 hr to control for diurnal rhythms in T
(Rose et al., 1972). Participants completed
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health and background questionnaires. Par-
ticipants indicated the length of their men-
strual cycles by selecting either: 23 days or
less, 24–26 days, 27–30 days, 31–34 days, or
35 or more days. Participants indicated the
regularity of their menses by selecting either:
perfectly regular, varies by 1–2 days, varies by
3–4 days, varies by 5–6 days, varies by 7 or
more days, or completely unpredictable. Par-
ticipants were asked whether they ever went
through long periods of time without having
their menstrual period (for reasons other than
pregnancy), and whether this had happened
in the last 12 months.
Saliva samples were collected in polysty-
rene tubes pretreated with sodium azide, and
frozen afterwards at 208C until assay. An
inert chewing gum was used to stimulate sa-
liva flow. Samples were assayed for T in four
batches at the Endocrine Core Laboratory at
Yerkes National Primate Research Center,
Emory University, in duplicate, using a modi-
fied kit from Diagnostic Systems Laboratories
(Webster, TX). Sensitivity was 2 pg/ml per
200-ml dose, and the interassay coefficient of
variation was 8.77% at 0.65 ng/ml and 6.88%
at 5.06 ng/ml. The intra-assay coefficient of
variation was 6.54% at 98.82 pg/ml.
Analysis
All analyses were performed with SPSS,
version 10.0.1. Age was controlled in all analy-
ses because of associations with increased T
and altered menstrual cycles. Means were ex-
amined with analyses of covariance (ANCOVA),
and associations with partial correlations. All
analyses excluded HC users, unless otherwise
indicated. Analyses did not control for sexual
orientation, since this did not alter the pattern
of results.
RESULTS
Salivary T and menstrual cycle length were
significantly correlated: partial r(158) ¼ 0.19,
P ¼ 0.015. We examined the means to address
whether high T might be present in women
with short as well as long cycles, as both can
be anomalous. However, higher T was associ-
ated with increased cycle length, and T was
highest in women with reported cycles of
35 days or more: F(1,158) ¼ 6.78, P ¼ 0.010
(Fig. 1).
T and irregularity of menstrual cycle onset
were significantly correlated: partial r(157) ¼
0.21, P ¼ 0.010. ANCOVA revealed that T was
significantly higher in those whose menstrual
onsets varied by 7 days or more, or were com-
pletely unpredictable: F(1,157) ¼ 6.69, P ¼
0.011 (Fig. 2).
We also conducted an ANCOVA to see
whether T was associated with amenorrhea.
Women with a history of missing menstrual
periods (M ¼ 26.69 pg/ml, SD ¼ 13.59, n ¼ 36)
had significantly higher T than other women
(M ¼ 20.79, SD ¼ 9.47, n ¼ 124): F(1,157) ¼
8.23, P ¼ 0.005. This phenomenon was most
pronounced in women who had missed periods
recently. Those who reported missed periods
in the last 12 months had significantly higher
salivary T (M ¼ 29.25 pg/ml, SD ¼ 16.18, n ¼
22) than other women (M ¼ 20.86 pg/ml, SD ¼
9.18, n ¼ 141): F(1,160) ¼ 11.54, P ¼ 0.001.
To address the possibility that the overall
correlation between T and cycle length might
be reducible to the data on women with missed
periods, we excluded women who reported
missed periods in the past 12 months and
reran the correlational analyses. Salivary T
and menstrual cycle length remained signifi-
cantly correlated: partial r(135) ¼ 0.18, P ¼
0.033. The partial correlation between T and
menstrual cycle irregularity approached signi-
ficance: partial r(134) ¼ 0.15, P ¼ 0.076. Thus,
the association between high T and menstrual
irregularities exists even in women with regu-
larly occurring periods.
In HC users, T was significantly and posi-
tively correlated with irregularity of men-
strual onset, at r(21) ¼ 0.71, P < 0.001, but
not with menstrual cycle length: partial
r(21) ¼ 0.08, P ¼ 0.704. HC users who had
ever missed periods (M ¼ 18.69 pg/ml, SD ¼
8.77, n ¼ 5) had higher T than other HC users
(M ¼ 12.82 pg/ml, SD ¼ 4.63, n ¼ 19), but not
significantly so: F(1,21) ¼ 3.01, P ¼ 0.097. Two
women had had long periods of time without
Fig. 1. Mean salivary testosterone (pg/ml) and stand-
ard error bars by self-reported regularity of menstrual
cycle onset. *Significant difference at a < 0.05.
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menstruating in the past year, and their mean
T was higher (25.79 pg/ml, SD ¼ 11.67) than
the other women (M ¼ 12.55 pg/ml, SD ¼ 4.46).
Thus, HC users demonstrated the same pat-
tern of high T-menstrual irregularities as non-
HC users.
To see how HC use was associated with T
levels, we conducted an ANCOVA. Nonusers
(M ¼ 22.06 pg/ml, SD ¼ 10.68) had signifi-
cantly higher T than HC-users (M ¼ 13.57,
SD ¼ 6.05): F(1,188) ¼ 15.25, P < 0.001, pre-
sumably secondary to HC-induced suppres-
sion of gonadotropin secretion.
DISCUSSION
The present study examined the association
between androgen levels (salivary T) and men-
strual irregularities in a sample of healthy
women. Women with longer cycles and more
irregular menstrual onset had higher T, even
when analyses included only regularly cycling
women. Additionally, women with missed pe-
riods ever and in the past 12 months had
higher circulating T. The data from this healthy
sample accord with previous studies of clinical
populations of adult women (Ayala et al., 1999),
as well as nonclinical adolescent populations
(Rodrigues Fernandez et al., 2005), but this is
the first study (to our knowledge) to extend this
to healthy adult women.
Surprisingly, high T was associated with
menstrual irregularities, even in HC users.
Since modern HCs are \low dose," and Spell-
acy et al. (1980) found that lower estrogen did
not strongly suppress gonadotropins, it may
be that an extant high T-menstrual irregular-
ity pattern is not greatly altered by HC use.
One limitation of the present study is the use
of self-report of past menstruation; the results
could be strengthened through the use of lon-
gitudinal designs.
High levels of androgens are associated with
a decreased likelihood of conception (Fukuda
et al., 2003) and with increased risk of breast
cancer in women (Micheli et al., 2004; Stur-
geon et al., 2004; Kaaks et al., 2005). Thus,
menstrual irregularity may be an important
and easily detected indicator of underlying or
potential physiological health problems. How-
ever, it is unlikely that many of the women
participating in this study had undiagnosed
neuroendocrine disorders (such as sub- or pre-
clinical PCOS) that would explain the results,
as participants self-reported good health, and
there were no other potential markers of neu-
roendocrine disorders (e.g., higher weight).
The functional significance of the association
between T and menstrual cyclicity in normal
healthy women thus awaits further study.
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